|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 27 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INCY |
Incyte Corp |
Director |
|
2010-09-22 |
4 |
S |
$14.71 |
$71,043 |
I/I |
(4,829) |
163,559 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2011-12-09 |
4 |
B |
$13.19 |
$64,462 |
I/I |
4,862 |
341,214 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-16 |
4 |
B |
$28.96 |
$145,350 |
I/I |
4,889 |
210,320 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-01 |
4 |
S |
$14.51 |
$71,406 |
I/I |
(4,920) |
283,366 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-30 |
4 |
B |
$16.44 |
$81,953 |
I/I |
4,984 |
1,150,104 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-07-31 |
4 |
B |
$9.00 |
$44,973 |
I/I |
4,997 |
134,054 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-28 |
4 |
B |
$4.02 |
$20,127 |
I/I |
5,010 |
83,778 |
2.17 |
- |
|
INCY |
Incyte Corp |
Director |
|
2023-06-14 |
4 |
A |
$0.00 |
$0 |
I/I |
5,010 |
33,445,860 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-30 |
4 |
B |
$18.08 |
$90,801 |
I/I |
5,012 |
287,514 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-12-22 |
4 |
B |
$3.85 |
$19,533 |
I/I |
5,072 |
11,604 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2008-06-06 |
4 |
B |
$20.01 |
$103,080 |
I/I |
5,102 |
92,236 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-11 |
4 |
B |
$5.42 |
$27,846 |
I/I |
5,127 |
65,585 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-03 |
4 |
S |
$13.29 |
$68,668 |
I/I |
(5,166) |
473,530 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-08 |
4 |
S |
$12.72 |
$65,937 |
I/I |
(5,183) |
570,585 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-21 |
4 |
B |
$27.98 |
$145,955 |
I/I |
5,217 |
1,411,266 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-23 |
4 |
B |
$4.96 |
$26,042 |
I/I |
5,251 |
11,155 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-23 |
4/A |
B |
$4.96 |
$26,156 |
I/I |
5,274 |
11,155 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-08 |
4 |
B |
$26.17 |
$139,904 |
I/I |
5,340 |
197,404 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-03-09 |
4 |
B |
$18.28 |
$98,260 |
I/I |
5,375 |
38,467 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-01-04 |
4 |
S |
$13.14 |
$70,709 |
I/I |
(5,380) |
468,150 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-11 |
4 |
B |
$5.42 |
$29,416 |
I/I |
5,416 |
80,396 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2010-05-25 |
4 |
B |
$11.95 |
$64,722 |
I/I |
5,416 |
11,119,820 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-12 |
4 |
B |
$5.58 |
$30,312 |
I/I |
5,434 |
29,619 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-08-23 |
4 |
B |
$16.97 |
$92,814 |
I/I |
5,468 |
1,770,681 |
1.5 |
- |
|
KOD |
Kodiak Sciences Inc. |
Director |
|
2022-01-25 |
4 |
B |
$58.90 |
$323,934 |
I/I |
5,500 |
14,027,837 |
2.25 |
% |
|
1397 Records found
|
|
Page 27 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|